Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2265 | 2231 | 57.1 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
168 | 21544 | ASYMMETRIC DIMETHYLARGININE//ENDOTHELIUM//ADMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NADPH OXIDASE | Author keyword | 160 | 21% | 30% | 666 |
2 | NOX1 | Author keyword | 90 | 70% | 3% | 74 |
3 | NOX4 | Author keyword | 71 | 53% | 4% | 95 |
4 | APOCYNIN | Author keyword | 44 | 42% | 4% | 82 |
5 | NOXA1 | Author keyword | 33 | 100% | 1% | 13 |
6 | NOXO1 | Author keyword | 30 | 100% | 1% | 12 |
7 | NOX5 | Author keyword | 29 | 88% | 1% | 14 |
8 | P22PHOX | Author keyword | 26 | 46% | 2% | 43 |
9 | NADPH OXIDASES | Author keyword | 16 | 41% | 1% | 29 |
10 | NOX2 | Author keyword | 15 | 33% | 2% | 39 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NADPH OXIDASE | 160 | 21% | 30% | 666 | Search NADPH+OXIDASE | Search NADPH+OXIDASE |
2 | NOX1 | 90 | 70% | 3% | 74 | Search NOX1 | Search NOX1 |
3 | NOX4 | 71 | 53% | 4% | 95 | Search NOX4 | Search NOX4 |
4 | APOCYNIN | 44 | 42% | 4% | 82 | Search APOCYNIN | Search APOCYNIN |
5 | NOXA1 | 33 | 100% | 1% | 13 | Search NOXA1 | Search NOXA1 |
6 | NOXO1 | 30 | 100% | 1% | 12 | Search NOXO1 | Search NOXO1 |
7 | NOX5 | 29 | 88% | 1% | 14 | Search NOX5 | Search NOX5 |
8 | P22PHOX | 26 | 46% | 2% | 43 | Search P22PHOX | Search P22PHOX |
9 | NADPH OXIDASES | 16 | 41% | 1% | 29 | Search NADPH+OXIDASES | Search NADPH+OXIDASES |
10 | NOX2 | 15 | 33% | 2% | 39 | Search NOX2 | Search NOX2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NADPH OXIDASE | 139 | 12% | 49% | 1093 |
2 | P22 PHOX GENE | 85 | 81% | 2% | 51 |
3 | NADH NADPH OXIDASE | 57 | 51% | 4% | 80 |
4 | NOX1 DEFICIENT MICE | 44 | 74% | 1% | 32 |
5 | P22PHOX | 40 | 63% | 2% | 40 |
6 | NOX4 | 40 | 52% | 2% | 54 |
7 | NADPH OXIDASE 1 | 35 | 76% | 1% | 25 |
8 | COLON EPITHELIAL CELLS | 35 | 52% | 2% | 48 |
9 | DEPENDENT CHRONIC HYPERTENSION | 26 | 87% | 1% | 13 |
10 | NOX1 | 25 | 60% | 1% | 28 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement | 2015 | 7 | 179 | 60% |
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology | 2007 | 2000 | 910 | 25% |
Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System | 2012 | 162 | 377 | 64% |
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets | 2011 | 221 | 219 | 57% |
Nox proteins in signal transduction | 2009 | 298 | 199 | 68% |
Nox enzymes and the biology of reactive oxygen | 2004 | 1407 | 60 | 38% |
The NOX toolbox: validating the role of NADPH oxidases in physiology and disease | 2012 | 86 | 181 | 72% |
NADPH Oxidases in Vascular Pathology | 2014 | 15 | 206 | 66% |
Reactive Oxygen Species, Vascular Noxs, and Hypertension: Focus on Translational and Clinical Research | 2014 | 20 | 213 | 50% |
Vascular NAD(P)H oxidases: specific features, expression, and regulation | 2003 | 578 | 217 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | KARDIOVASKULARE PHYSIOL | 12 | 31% | 1.4% | 31 |
2 | AUDIE L MURPHY MEM HOSP | 5 | 47% | 0.4% | 8 |
3 | WMB 319 | 4 | 75% | 0.1% | 3 |
4 | CARDIOVASC KIDNEY | 4 | 41% | 0.3% | 7 |
5 | VET MOL BIOL | 4 | 11% | 1.3% | 29 |
6 | AUDIE LEON MURPHY MEM HOSP | 3 | 100% | 0.1% | 3 |
7 | AUDIE MURPHY MEM VET ADM HOSP | 3 | 100% | 0.1% | 3 |
8 | BIOL AGEING S | 3 | 100% | 0.1% | 3 |
9 | NEPHROL MC 7882 | 3 | 100% | 0.1% | 3 |
10 | CELL SYNTHET INTER E ENGN | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000175267 | NA DEPENDENT CA2 UPTAKE//TISSUE INHIBITOR OF METALLOPROTEASE 2//PULMONARY ARTERY SMOOTH MUSCLE |
2 | 0.0000165552 | MYOCARDIOL BIOL UNIT//PROGRAM LIFELONG LEARNING STUDIES//MYOCARDIAL UNIT |
3 | 0.0000110771 | SULFENIC ACID//HSP33//CYSTEINE OXIDATION |
4 | 0.0000104691 | HUMAN TOXICOL PROGRAM//PROGRAM FREE RAD RADIAT BIOL//BIOQUIM BIOQUIM BIOL MOL |
5 | 0.0000100071 | CHRONIC GRANULOMATOUS DISEASE//CYTOCHROME B558//CGD |
6 | 0.0000077708 | ABBOUD CARDIOVASC//ARTERIAL ANTIGEN//IVIC ZULIA |
7 | 0.0000077197 | 2 HYDROXYETHIDIUM//HYDROETHIDINE//L 012 |
8 | 0.0000076921 | EXTRACELLULAR SUPEROXIDE DISMUTASE//EC SOD//EXTRACELLULAR SUPEROXIDE DISMUTASE EC SOD |
9 | 0.0000072790 | DIHYDROXYFUMARATE//LD 1227//MONDINO TOR VERGATA NEUROPHARMACOL |
10 | 0.0000072396 | PRIMA CLIN MED//BIOMED EVOLUT AGING//CLIN LIPID |